Type 2 diabetes mellitus is the leading cause of chronic kidney disease. Clinical measures of kidney function often detect dysfunction after irreversible damage has occurred. This highlights an unmet need for a biomarker that can enable earlier detection of disease. Quantification of renal metabolic rate of oxygen is a promising metric because it increases by 40-65% during the early stages of diabetic kidney disease. Here, we propose a “difference method” to quantify bilateral renal metabolic rate of oxygen by imaging above and below the renal vessels and exploiting conservation of blood flow rate and mass.
This abstract and the presentation materials are available to members only; a login is required.